{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:25:45Z","timestamp":1785522345007,"version":"3.56.0"},"reference-count":36,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Novo Nordisk Foundation Pandemic Antiviral Discovery","award":["NNF24SA0097217"],"award-info":[{"award-number":["NNF24SA0097217"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2026,2,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Influenza A virus (IAV) causes annual epidemics and sporadic pandemics of acute respiratory infections resulting in significant morbidity and mortality. Although approved influenza antivirals (e.g., oseltamivir and baloxavir) exist, concerns persist about the potential for emergence of drug-resistant variants, highlighting the continuing need for new antiviral therapies. Here, we describe the development of an orally bioavailable, direct-acting antiviral (VNT-101) with a novel mechanism of action: disrupting homo-oligomerization of the influenza nucleoprotein (NP) and thereby inhibiting viral RNA synthesis. Selection of drug-resistant mutants revealed amino acid substitutions mapping to the oligomerization domain of NP, and X-ray crystallography co-structure determination of VNT-101 complexed with recombinant NP confirmed VNT-101 binding in the oligomerization pocket. Biochemical experiments using size exclusion chromatography confirmed disruption of oligomerization when this chemotype is added to preparations of recombinant NP\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      . VNT-101 has potent and specific activity against the currently circulating IAV subtypes H1N1 and H3N2, with mean EC\n                      <jats:sub>50<\/jats:sub>\n                      values ranging from 2 to 18 nM, and displays strong efficacy in a murine model of lethal influenza infection when administered either prophylactically or therapeutically. Importantly, VNT-101 remains active against influenza variants that are resistant to either oseltamivir or baloxavir and also has potent activity against highly pathogenic avian H5N1 and H7N9 isolates that have transmitted to humans and represent strains of potential pandemic concern. These studies support the continued development of VNT-101 to augment our therapeutic arsenal against both seasonal and pandemic influenza.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/aac.01149-25","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:05:36Z","timestamp":1766153136000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization"],"prefix":"10.1128","volume":"70","author":[{"given":"Vincent H. J.","family":"Leonard","sequence":"first","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Infectious Diseases","place":["Emeryville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna B.","family":"Vidales","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Infectious Diseases","place":["Emeryville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1129-7618","authenticated-orcid":true,"given":"Benjamin R.","family":"Taft","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Global Discovery Chemistry","place":["Emeryville, USA"]},{"name":"Via Nova Therapeutics","place":["Oakland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4759-5086","authenticated-orcid":true,"given":"Matthew J.","family":"Hesse","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Global Discovery Chemistry","place":["Emeryville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Lee","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Global Discovery Chemistry","place":["Emeryville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulugeta","family":"Mamo","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Global Discovery Chemistry","place":["Emeryville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirksen E.","family":"Bussiere","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Global Discovery Chemistry","place":["Emeryville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen C.","family":"Wolff","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/017136v53","id-type":"ROR","asserted-by":"publisher"}],"name":"Genomics Institute of the Novartis Research Foundation","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli L.","family":"Kuhen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/017136v53","id-type":"ROR","asserted-by":"publisher"}],"name":"Genomics Institute of the Novartis Research Foundation","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wedel","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Infectious Diseases","place":["Emeryville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellena","family":"Growcott","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Infectious Diseases","place":["Emeryville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Osborne","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Infectious Diseases","place":["Emeryville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassio P.","family":"Octaviani","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/016tfm930","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology and Immunology, University of Texas Medical Branch","place":["Galveston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinghan","family":"Huang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/016tfm930","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology and Immunology, University of Texas Medical Branch","place":["Galveston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Te Kent","family":"Tseng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/016tfm930","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology and Immunology, University of Texas Medical Branch","place":["Galveston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9094-0562","authenticated-orcid":true,"given":"Johanna R.","family":"Abend","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Infectious Diseases","place":["Emeryville, USA"]},{"name":"Via Nova Therapeutics","place":["Oakland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4959-8787","authenticated-orcid":true,"given":"Kelly A.","family":"Wong","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Infectious Diseases","place":["Emeryville, USA"]},{"name":"Via Nova Therapeutics","place":["Oakland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Infectious Diseases","place":["Emeryville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2249-8669","authenticated-orcid":true,"given":"David C.","family":"Tully","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Global Discovery Chemistry","place":["Emeryville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0250-2314","authenticated-orcid":true,"given":"Don","family":"Ganem","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Infectious Diseases","place":["Emeryville, USA"]},{"name":"Via Nova Therapeutics","place":["Oakland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12486"},{"key":"e_1_3_4_3_2","unstructured":"Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases (NCIRD). 2024. Disease burden of flu. Available from: https:\/\/www.cdc.gov\/flu\/about\/burden"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00982-5"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3367"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038398"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62449-1"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19053018"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S105473"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0900648"},{"key":"e_1_3_4_11_2","unstructured":"Baloxavir USPI. 2018. South San Francisco CA USA"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716197"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0609-0"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27890-4"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03026"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c01233"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1638"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2162798"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05379"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-112110"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1107\/S2053230X2100635X"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9818"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1113107108"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2008.12.014"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13061011"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw857"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568026618666180531092503"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep29684"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1107906108"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217307"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy547"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00469-2"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444911007773"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0021889807021206"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444910007493"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444912001308"},{"key":"e_1_3_4_37_2","volume-title":"Global Phasing Limited (GPhL)","author":"Bricogne G","year":"2017","unstructured":"Bricogne G, Blanc E, Brandl M, Flensburg C, Keller P, Paciorek W, Roversi P, Sharff A, Smart OS, Vonrhein C, Womack TO. 2017. BUSTER version X.Y.Z. In Global Phasing Limited (GPhL). Cambridge, UK."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01149-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01149-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:01:28Z","timestamp":1770213688000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.01149-25"}},"subtitle":[],"editor":[{"given":"Zhaohui","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,4]]}},"alternative-id":["10.1128\/aac.01149-25"],"URL":"https:\/\/doi.org\/10.1128\/aac.01149-25","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"2025-07-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01149-25"}}